Home › Funds › Prosight Management, LP › TECX

Prosight Management, LP position in TECX

TECTONIC THERAPEUTIC INC · Health Care

Prosight Management, LP reported holding 39,731 shares of TECX (TECTONIC THERAPEUTIC INC) in its Q2 2026 13F filing — a position valued at US$1.4M, representing 0.24% of its reported portfolio and ranking #31 among its reported holdings. Prosight Management, LP has disclosed TECX holdings in 8 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)39.73K sh
Reported value held$1.37M
Portfolio Weight0.24%
First reportedQ2 2024
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Prosight Management, LP's TECX position evolved

Prosight Management, LP first disclosed a stake in TECX in Q2 2024 at 67,461 shares (US$1.1M). The position peaked in Q2 2025 at 442,056 shares, worth US$8.8M. Across 8 filings, Prosight Management, LP increased the stake 2 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 39,731 shares valued at US$1.4M — a reduction of -40,141 shares quarter over quarter.. Notable position changes include a 104% increase in Q3 2024, a 66% trim in Q1 2026 (shares rose 11% over the following quarter), a 50% trim in Q2 2026 (shares fell 32% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 67.46K $1.11M New
Q3 2024 137.61K $4.17M Add
Q1 2025 398.88K $7.06M New
Q2 2025 442.06K $8.78M Add
Q3 2025 379.25K $5.95M Reduce
Q4 2025 235.00K $4.90M Reduce
Q1 2026 79.87K $2.47M Reduce
Q2 2026 39.73K $1.37M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TECX and 13F data

TECX (TECTONIC THERAPEUTIC INC) is a Health Care company. 54 other funds we track also report a position in TECX — the largest reported positions include TCG Crossover Management, LLC (US$41.4M), First Light Asset Management, LLC (US$27.5M), 5AM Venture Management, LLC (US$20.9M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TECX

All TECX fund holders →

FAQ

How long has Prosight Management, LP held TECX?

Prosight Management, LP has disclosed TECX holdings in 8 of the last 9 reported quarters, going back to Q2 2024.

What is Prosight Management, LP's current position in TECX?

As of Q2 2026, Prosight Management, LP holds 39.73K shares of TECX (TECTONIC THERAPEUTIC INC), valued at $1.37M, representing 0.24% of its reported portfolio and ranking #31.

Has Prosight Management, LP been buying or selling TECX?

In the latest 13F filing (Q2 2026), Prosight Management, LP reduced its position in TECX. The position peaked in Q2 2025 at 442.06K shares.

Which other funds hold TECX?

Other major institutional holders of TECX include TCG Crossover Management, LLC, First Light Asset Management, LLC, 5AM Venture Management, LLC, among 54 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.